Changing Patterns of Relapse in Hodgkin's Disease
Author Information
Author(s): G. Duchesne, J. Crow, S. Ashley, M. Bradal, A. Horwich
Primary Institution: Institute of Cancer Research and Royal Marsden Hospital
Hypothesis
What factors predict late relapse in patients with Hodgkin's disease who achieve complete remission?
Conclusion
The risk of late relapse in Hodgkin's disease has not decreased despite improvements in treatment, particularly in patients treated with radiotherapy.
Supporting Evidence
- The incidence of early relapse has progressively fallen with improved treatment.
- Patients treated with radiotherapy alone had a greater risk of late relapse compared to those receiving combined modality therapy.
- Factors such as stage II disease and absence of B symptoms at presentation were associated with a higher risk of late relapse.
Takeaway
Doctors studied patients with Hodgkin's disease to see when they might relapse after treatment. They found that even though many patients do well, some still relapse many years later.
Methodology
The study analyzed 432 patients who achieved complete remission after treatment for stage I and II Hodgkin's disease, focusing on the timing of relapses and factors predicting late relapse.
Potential Biases
Potential bias due to the retrospective nature of the study and the specific patient population.
Limitations
The study only included patients treated at one hospital and may not be generalizable to all populations.
Participant Demographics
Adult patients with early stage Hodgkin's disease treated between 1964 and 1983.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website